Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | -79.48%104.04M | ---- | ---- | ---- | -59.12%506.95M | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | -6.84%-59.44M | ---- | ---- | ---- | -6.39%-55.64M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | 106.19%85.68M | ---- | ---- | ---- | 383.80%41.55M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | 113.05%66.54M | ---- | ---- | ---- | 1,018.62%31.23M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | 85.43%19.14M | ---- | ---- | ---- | 78.06%10.32M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -54.28%106.51M | ---- | ---- | ---- | 163.77%232.95M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -54.28%106.51M | ---- | ---- | ---- | 163.77%232.95M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -559.67%-15.26M | ---- | ---- | ---- | 705.83%3.32M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -604.11%-15.47M | ---- | ---- | ---- | --3.07M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -16.33%210K | ---- | ---- | ---- | -39.08%251K | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 2.08%145.09M | ---- | ---- | ---- | 9.57%142.13M | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | 11.38%10.09M | ---- | ---- | ---- | -41.95%9.06M | ---- | ---- |
| Financial expense | ---- | ---- | ---- | -22.09%2.45M | ---- | ---- | ---- | -12.28%3.14M | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 105.65%684K | ---- | ---- | ---- | 55.79%-12.11M | ---- | ---- |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 226.14%6.03M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | -57.42%369.74M | ---- | ---- | ---- | -7.16%868.32M | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -91.35%13.73M | ---- | ---- | ---- | 165.57%158.67M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -106.19%-24.14M | ---- | ---- | ---- | 88.55%-11.71M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 117.80%15.91M | ---- | ---- | ---- | -172.21%-89.35M | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | 118.23%15.2M | ---- | ---- | ---- | -1,121.13%-83.41M | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 163.09%42.76M | ---- | ---- | ---- | -119.58%-67.77M | ---- | ---- |
| Cash from business operations | ---- | -18.34%187.4M | ---- | -44.08%433.2M | ---- | -31.81%229.49M | ---- | -27.52%774.75M | ---- | -42.94%336.54M |
| Other taxs | ---- | 47.21%-38.65M | ---- | 37.27%-95.8M | ---- | 19.12%-73.22M | ---- | -23.61%-152.72M | ---- | -104.56%-90.53M |
| Adjustment items of business operations | 38.51%266.39M | ---- | -45.69%65.15M | ---- | -57.11%192.33M | ---- | 977.61%119.95M | ---- | -42.38%448.44M | ---- |
| Net cash from operations | 38.51%266.39M | -4.82%148.75M | -45.69%65.15M | -45.76%337.4M | -57.11%192.33M | -36.48%156.28M | 977.61%119.95M | -34.21%622.03M | -42.38%448.44M | -54.90%246.01M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -67.42%62.04M | ---- | -51.10%5.61M | 130.77%3M | 741.85%190.46M | ---- | 470.08%11.48M | --1.3M | 25.45%22.62M | ---- |
| Decrease in deposits (increase) | ---- | 80.08%-266.39M | ---- | -3,048.42%-686.2M | ---- | -30,363.22%-1.34B | ---- | 37.41%-21.8M | ---- | --4.42M |
| Sale of fixed assets | 105.99%1.15M | -93.21%37K | -12.08%2.95K | 278.67%568K | 448.23%555.93K | 1,138.64%545K | -28.99%3.35K | 38.89%150K | 270.31%101.41K | 340.00%44K |
| Purchase of fixed assets | 35.58%-121.12M | 32.97%-86.03M | 20.67%-46.81M | -34.67%-251.53M | -25.64%-188.02M | -27.09%-128.35M | -5.61%-59.02M | 30.50%-186.78M | 31.43%-149.65M | 12.44%-100.99M |
| Selling intangible assets | ---- | -96.01%62.18M | ---- | ---- | ---- | --1.56B | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | -95.12%-3.28M | ---- | -200.44%-17.86M | ---- | 45.10%-1.68M | ---- | 2.40%-5.95M | ---- | -104.68%-3.06M |
| Sale of subsidiaries | ---- | ---- | ---- | --35M | ---- | --35M | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 95.51%-90.06M | 94.67%-90.06M | 88.04%-90.06M |
| Recovery of cash from investments | -17.51%1.9B | 213.13%967.27M | 574.22%612M | 190.87%1.76B | 360.20%2.31B | -3.78%308.9M | -56.09%90.77M | -33.32%605.05M | -34.87%501.5M | -47.90%321.04M |
| Cash on investment | 35.46%-2.11B | 5.58%-1.12B | -653.97%-904.76M | -354.51%-2.81B | -667.50%-3.27B | -576.51%-1.18B | -100.00%-120M | 17.85%-617.35M | 52.58%-426.08M | 74.54%-175M |
| Other items in the investment business | ---- | 418.42%23.02M | ---- | 80.47%1.53M | 108.25%9.2M | 196.00%4.44M | -32.44%9.2M | -96.68%850K | 132.60%4.42M | --1.5M |
| Net cash from investment operations | 72.14%-264.72M | 43.43%-420.99M | -394.30%-333.96M | -523.53%-1.96B | -592.72%-950.05M | -1,667.48%-744.23M | -163.45%-67.56M | 85.26%-314.58M | 93.25%-137.15M | 95.53%-42.11M |
| Net cash before financing | 100.22%1.67M | 53.70%-272.24M | -613.08%-268.81M | -628.25%-1.62B | -343.41%-757.73M | -388.35%-587.96M | -43.55%52.39M | 125.86%307.45M | 124.85%311.29M | 151.52%203.9M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 88.29%-6.9M | 66.54%-6.87M | -300.47%-6.82M |
| Interest paid - financing | ---- | -24.58%-223K | ---- | -8.86%-2.87M | ---- | 30.08%-179K | ---- | -25.48%-2.64M | ---- | 16.34%-256K |
| Dividends paid - financing | 81.29%-22.39M | ---- | ---- | 44.16%-119.63M | 44.18%-119.63M | ---- | ---- | -55.97%-214.24M | -55.72%-214.33M | ---- |
| Other items of the financing business | 71.67%-36.6M | 88.88%-10.34M | 50.79%-18.67M | -3.23%-117.25M | -15.26%-129.19M | -27.30%-92.93M | -58.46%-37.93M | -439.43%-113.58M | -308.34%-112.09M | -98,548.65%-73M |
| Net cash from financing operations | 76.29%-58.99M | 73.72%-28.18M | 50.79%-18.67M | 26.56%-265.63M | 25.34%-248.83M | -14.58%-107.25M | -52.61%-37.93M | -264.11%-361.68M | -285.81%-333.29M | -597.97%-93.6M |
| Effect of rate | 16.45%-5.82M | -932.79%-2.55M | 58.71%-1.15M | -84.79%1.28M | -150.50%-6.97M | -101.39%-247K | 55.43%-2.8M | -77.56%8.41M | -68.11%13.8M | -25.37%17.78M |
| Net Cash | 94.31%-57.32M | 56.79%-300.42M | -2,087.68%-287.48M | -3,384.52%-1.89B | -4,475.92%-1.01B | -730.29%-695.21M | -78.72%14.46M | 95.79%-54.23M | 98.36%-22M | 129.26%110.3M |
| Begining period cash | -66.18%965.2M | -66.18%965.2M | -66.18%965.2M | -1.58%2.85B | -1.58%2.85B | -1.58%2.85B | -1.58%2.85B | -30.14%2.9B | -30.14%2.9B | -30.14%2.9B |
| Cash at the end | -50.98%902.06M | -69.32%662.23M | -76.39%676.57M | -66.18%965.2M | -36.36%1.84B | -28.71%2.16B | -3.24%2.87B | -1.58%2.85B | 1.29%2.89B | -20.27%3.03B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.